Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preemptive renal transplantation: why not?

Kevin C Mange1, Matthew R Weir

  • 1Division of Renal-Electrolyte and Hypertension, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. kmange@cceb.med.upenn.edu

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|October 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Phase 2 Study of the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease.

Pulmonary circulation·2026
Same author

Brachial Artery Pulse Pressure: Perspectives on Pathophysiology in Women Without Obstructive Coronary Disease.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same author

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Enabling a Renin-Angiotensin System Inhibitor and/or a Mineralocorticoid Receptor Antagonist in Patients With Heart Failure and/or Chronic Kidney Disease: Unintended Consequences of Increased Sodium Exposure.

JACC. Heart failure·2026
Same author

Impact of older donor age in kidney transplants in a biopsy-based observational study.

JCI insight·2026

Preemptive renal transplantation (PRT) before dialysis is increasingly recognized as the optimal strategy for end-stage renal disease patients. Evidence suggests PRT offers significant benefits for renal replacement therapy outcomes.

Area of Science:

  • Nephrology
  • Transplantation Medicine
  • Renal Replacement Therapy

Background:

  • Dialysis is the traditional initial treatment for end-stage renal disease (ESRD).
  • Preemptive renal transplantation (PRT), transplantation before initiating dialysis, has been debated due to limited evidence on its benefits versus risks.
  • Recent observational studies suggest PRT may be the superior strategy for patients needing renal replacement therapy.

Purpose of the Study:

  • To review the advantages of preemptive renal transplantation (PRT).
  • To summarize research on the impact of transplantation timing on patient outcomes.
  • To explore the utility and challenges of expanding PRT access.

Main Methods:

  • Literature review of observational analyses and studies on renal transplantation timing.

Related Experiment Videos

  • Synthesis of evidence regarding the benefits and risks of PRT compared to dialysis initiation.
  • Discussion of various perspectives on PRT implementation.
  • Main Results:

    • Recent observational analyses indicate PRT is an optimal strategy for patients requiring renal replacement therapy.
    • Evidence is accumulating to support the benefits of PRT over traditional dialysis initiation.
    • The timing of renal transplantation significantly impacts patient outcomes.

    Conclusions:

    • Preemptive renal transplantation (PRT) is emerging as the preferred approach for end-stage renal disease management.
    • Further research and strategies are needed to overcome challenges in expanding PRT access.
    • PRT offers a potentially more beneficial pathway for patients requiring renal replacement therapy.